Updates in Targeted Combination Therapies for Melanoma

Approximately 40% of melanoma cases harbor BRAF mutations that are able to be targeted, and with the advent of the combination of dabrafenib (Tafinlar) plus trametinib (Mekinist) demonstrating impressive outcomes in patients with BRAF mutations, physicians are no longer using BRAF inhibitors alone, but rather in combination with MEK inhibitors due to the improved efficacy.

Versatile Sensor Against Tumor Initiating Cells

Most cancer deaths are caused by recurrent or metastatic tumors.

Larger Trials Needed to Confirm Benefit of Targeted Therapies, Immunotherapy for Brain Metastases

Brain metastases are a common complication of a variety of cancer types and a major cause of morbidity and mortality.

New Skin Cancer Jab is Created by British Scientists Who Have Even Identified How to Predict Which Patients it can Save

British scientists have created a cancer vaccine that fights the most deadly type of skin cancer – and learned how to predict who it will work for.

Cancer in the News

Feature Articles

Obesity Associated with Longer Survival for Men with Metastatic Melanoma

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.

Read the full story

Posted in Melanoma In The News, Information

Focus Moves to Earlier Settings in Melanoma

Novel systemic therapies in the neoadjuvant and adjuvant settings have shown promising outcomes for locally advanced melanoma and may reduce the proportion of patients who need complete lymphadenectomy.

Read the full story

Posted in Melanoma In The News, Information

Obesity Associated with Longer Survival for Men with Metastatic Melanoma

Source: Eurek Alert, February 2018 Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts. This effect, referred to as the “Obesity Paradox”, […]

Read the full story

Posted in Melanoma In The News, Information

Townsville’s First Ever Twilight Melanoma March

She will next month join Townsville’s first ever twilight Melanoma March in honour of her mother, Gina Sellen, who lost her battle against the deadly cancer in 2016.

Read the full story

Posted in Melanoma In The News, Supporters Events

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories